Innovations in Digital Health to Improve Care Delivery Date: Tue, Mar 19th, 2024 Time: 8:00 am - 9:00 am Location: Online
Speaker:
Thomas M. Maddox, MD Disclosures: Dr. Maddox receives Grant funding from the NIH (NHLBI UG3HL165065: The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF); Honoraria and expense reimbursement from the University of Chicago, George Washington University, Baylor College of Medicine, the New York Cardiological Society, Medscape, University of Utah, the Association of Health Care Journalists, the University of North Carolina at Chapel Hill, and Wake Forest University; Compensation and travel expense reimbursement for American College of Cardiology board activities; Employment as a cardiologist and Executive Director, Healthcare Innovation Lab at BJC HealthCare/ Washington University School of Medicine. In this capacity, he is advising Myia Labs, for which his employer is receiving equity compensation in the company. He is receiving no individual compensation from the company; Compensation as a director for a New Mexico-based foundation, the J.F Maddox Foundation.
> Explain the role of predictive analytics in clinical practice.
> Understand the role of digital point-of-care tools in clinical practice.
> Identify the role of remote patient monitoring in clinical practice.
Accreditation
NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
NewYork Presbyterian/Queens designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with
commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.